IMMUNOTHERAPY AND INNOVATIVE CELLULAR THERAPIES IN HAEMATOLOGICAL NEOPLASIA
Academic year and teacher
If you can't find the course description that you're looking for in the above list,
please see the following instructions >>
- Versione italiana
- Academic year
- 2021/2022
- Teacher
- ANTONIO CUNEO
- Credits
- 2
- Didactic period
- Secondo Semestre
- SSD
- MED/15
Training objectives
- Learning the basic elements of modern therapy with monoclonal antibodies and with chimeric antigen receptor T-cells (CAR-T cells) in hemopoietic neoplasms
Prerequisites
- Basic principles of therapy of lymphomas and myeloma
Course programme
- Structure, mechanism of action and employment of
- anti CD20 and anti CD38 monoclonal antibodies
- Monoclonal antibodies with toxin conjugate
- chimeric antigen receptor T-cells (CAR-T cells) Didactic methods
- Lectures – case reoprts
Learning assessment procedures
- Oral examination
Oral examination. Two questions about two different topics will be asked. The state of knowledge of the subject, the clarity and the ability to apply the information to clinical practice will be evaluated. The average duration of the exam will be 20 -25 minutes. To pass the exam it is necessary to get at least 18 point out of 30. Reference texts
- Harrison textbook of internal medicine – McGraw-Hill
